High prevalence of eosinophilic esophagitis in patients with inherited connective tissue disorders

Journal of Allergy and Clinical Immunology

Volumn 132, Issue 2, 2013, Pages 378-386

  Abonia, J Pablo ^a   Wen, Ting ^a   Stucke, Emily M ^a   Grotjan, Tommie ^a   Griffith, Molly S ^a   Kemme, Katherine A ^a   Collins, Margaret H ^a   Putnam, Philip E ^a   Franciosi, James P ^b   Von Tiehl, Karl F ^a   Tinkle, Brad T ^c   Marsolo, Keith A ^a   Martin, Lisa J ^a   Ware, Stephanie M ^a   Rothenberg, Marc E ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b NEMOURS CHILDREN S HOSPITAL   (United States)

^c Lutheran General Hospital   (United States)

Author keywords

connective tissue disorders; Ehlers Danlos syndrome; eosinophil; Eosinophilic esophagitis; eosinophilic gastrointestinal disease; hypermobility syndrome; Marfan syndrome

Indexed keywords

MESSENGER RNA;

ARTICLE; CHILD; CLINICAL ARTICLE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DATA BASE; ELECTRONIC MEDICAL RECORD; EOSINOPHILIC ESOPHAGITIS; FEMALE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD;

BMI; BODY MASS INDEX; CCHMC; CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER; CONNECTIVE TISSUE DISORDER; CONNECTIVE TISSUE DISORDERS; CTD; EDS; EGID; EHLERS-DANLOS SYNDROME; ELECTRONIC MEDICAL RECORD; EMR; EOE; EOSINOPHIL; EOSINOPHILIC ESOPHAGITIS; EOSINOPHILIC GASTROINTESTINAL DISEASE; EOSINOPHILIC GASTROINTESTINAL DISORDER; FBN1; FIBRILLIN-1 GENE; GASTROESOPHAGEAL REFLUX DISEASE; GERD; HYPERMOBILITY SYNDROME; I2B2; INFORMATICS FOR INTEGRATING BIOLOGY & THE BEDSIDE; JHS; JOINT HYPERMOBILITY SYNDROME; LDS; LOEYS-DIETZ SYNDROME; MARFAN SYNDROME; MFS; PPI; PROTON PUMP INHIBITOR;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COLLAGEN TYPE VIII; CONNECTIVE TISSUE DISEASES; EHLERS-DANLOS SYNDROME; EOSINOPHILIC ESOPHAGITIS; ESOPHAGUS; FEMALE; HUMANS; MALE; MARFAN SYNDROME; PREVALENCE; RNA, MESSENGER;

EID: 84881167455     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2013.02.030     Document Type: Article

References (59)

1. C.A. Liacouras, G.T. Furuta, I. Hirano, D. Atkins, S.E. Attwood, and P.A. Bonis Eosinophilic esophagitis: updated consensus recommendations for children and adults J Allergy Clin Immunol 128 2011 3 20
2. R.C. Kapel, J.K. Miller, C. Torres, S. Aksoy, R. Lash, and D.A. Katzka Eosinophilic esophagitis: a prevalent disease in the United States that affects all age groups Gastroenterology 134 2008 1316 1321
3. A. Straumann, and H.U. Simon Eosinophilic esophagitis: escalating epidemiology? J Allergy Clin Immunol 115 2005 418 419
4. K.J. Kelly, A.J. Lazenby, P.C. Rowe, J.H. Yardley, J.A. Perman, and H.A. Sampson Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula Gastroenterology 109 1995 1503 1512
5. J.M. Spergel, T. Andrews, T.F. Brown-Whitehorn, J.L. Beausoleil, and C.A. Liacouras Treatment of eosinophilic esophagitis with specific food elimination diet directed by a combination of skin prick and patch tests Ann Allergy Asthma Immunol 95 2005 336 343
6. C.J. Henderson, J.P. Abonia, E.C. King, P.E. Putnam, M.H. Collins, and J.P. Franciosi Comparative dietary therapy effectiveness in remission of pediatric eosinophilic esophagitis J Allergy Clin Immunol 129 2012 1570 1578
7. N. Gonsalves, G.Y. Yang, B. Doerfler, S. Ritz, A.M. Ditto, and I. Hirano Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors Gastroenterology 142 2012 1451 1459
8. A. Mishra, S.P. Hogan, E.B. Brandt, and M.E. Rothenberg An etiological role for aeroallergens and eosinophils in experimental esophagitis J Clin Invest 107 2001 83 90
9. C. Blanchard, N. Wang, K.F. Stringer, A. Mishra, P.C. Fulkerson, and J.P. Abonia Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis J Clin Invest 116 2006 536 547
10. M.E. Rothenberg, J.M. Spergel, J.D. Sherrill, K. Annaiah, L.J. Martin, and A. Cianferoni Common variants at 5q22 associate with pediatric eosinophilic esophagitis Nat Genet 42 2010 289 291
11. J.D. Sherrill, P.S. Gao, E.M. Stucke, C. Blanchard, M.H. Collins, and P.E. Putnam Variants of thymic stromal lymphopoietin and its receptor associate with eosinophilic esophagitis J Allergy Clin Immunol 126 2010 160 165
12. J.D. Sherrill, and M.E. Rothenberg Genetic dissection of eosinophilic esophagitis provides insight into disease pathogenesis and treatment strategies J Allergy Clin Immunol 128 2011 23 32
13. S.S. Aceves, R.O. Newbury, D. Chen, J. Mueller, R. Dohil, and H. Hoffman Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids Allergy 65 2010 109 116
14. S.S. Aceves, D. Chen, R.O. Newbury, R. Dohil, J.F. Bastian, and D.H. Broide Mast cells infiltrate the esophageal smooth muscle in patients with eosinophilic esophagitis, express TGF-beta1, and increase esophageal smooth muscle contraction J Allergy Clin Immunol 126 2010 1198 1204
15. J.P. Abonia, J.P. Franciosi, and M.E. Rothenberg TGF-beta1: Mediator of a feedback loop in eosinophilic esophagitis - or should we really say mastocytic esophagitis? J Allergy Clin Immunol 126 2010 1205 1207
16. J. Fuentebella, A. Patel, T. Nguyen, B. Sanjanwala, W. Berquist, and J.A. Kerner Increased number of regulatory T cells in children with eosinophilic esophagitis J Pediatr Gastroenterol Nutr 51 2010 283 289
17. X. Zhu, M. Wang, C.H. Crump, and A. Mishra An imbalance of esophageal effector and regulatory T cell subsets in experimental eosinophilic esophagitis in mice Am J Physiol Gastrointest Liver Physiol 297 2009 G550 G558
18. E.R. Neptune, P.A. Frischmeyer, D.E. Arking, L. Myers, T.E. Bunton, and B. Gayraud Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome Nat Genet 33 2003 407 411
19. M.E. Lindsay, D. Schepers, N.A. Bolar, J.J. Doyle, E. Gallo, and J. Fert-Bober Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm Nat Genet 44 2012 922 927
20. P.A. De, L. Nuytinck, I. Hausser, I. Anton-Lamprecht, and J.M. Naeyaert Mutations in the COL5A1 gene are causal in the Ehlers-Danlos syndromes I and II Am J Hum Genet 60 1997 547 554
21. S. Symoens, M. Renard, C. Bonod-Bidaud, D. Syx, E. Vaganay, and F. Malfait Identification of binding partners interacting with the alpha1-N-propeptide of type V collagen Biochem J 433 2011 371 381
22. S. Kahai, C.P. Vary, Y. Gao, and A. Seth Collagen, type V, alpha1 (COL5A1) is regulated by TGF-beta in osteoblasts Matrix Biol 23 2004 445 455
23. H.C. Habein Ehlers-Danlos syndrome with spontaneous rupture of the esophagus. Report of first case Rocky Mt Med J 74 1977 78 80
24. E.D. Reis, O.D. Martinet, and F. Mosimann Spontaneous rupture of the oesophagus in an adolescent with type IV Ehlers-Danlos syndrome. Ehlers-Danlos and spontaneous oesophageal rupture Eur J Surg 164 1998 313 316
25. R. Eliashar, J.Y. Sichel, A. Biron, and I. Dano Multiple gastrointestinal complications in Marfan syndrome Postgrad Med J 74 1998 495 497
26. A.L. Buchman, D. Wolf, and T. Gramlich Eosinophilic gastrojejunitis associated with connective tissue disease South Med J 89 1996 327 330
27. K. DeSchryver-Kecskemeti, and R.E. Clouse A previously unrecognized subgroup of "eosinophilic gastroenteritis." Association with connective tissue diseases Am J Surg Pathol 8 1984 171 180
28. S.N. Murphy, M.E. Mendis, D.A. Berkowitz, I. Kohane, and H.C. Chueh Integration of clinical and genetic data in the i2b2 architecture AMIA Annu Symp Proc 2006 1040
29. M. Mendis, L.C. Phillips, R. Kuttan, W. Pan, V. Gainer, and I. Kohane Integrating outside modules into the i2b2 architecture AMIA Annu Symp Proc 2008 1054
30. C. Blanchard, M.K. Mingler, M. Vicario, J.P. Abonia, Y.Y. Wu, and T.X. Lu IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids J Allergy Clin Immunol 120 2007 1292 1300
31. C.W. DeBrosse, J.W. Case, P.E. Putnam, M.H. Collins, and M.E. Rothenberg Quantity and distribution of eosinophils in the gastrointestinal tract of children Pediatr Dev Pathol 9 2006 210 218
32. T. Lwin, S.D. Melton, and R.M. Genta Eosinophilic gastritis: histopathological characterization and quantification of the normal gastric eosinophil content Mod Pathol 24 2011 556 563
33. J. Dent, H.B. El-Serag, M.A. Wallander, and S. Johansson Epidemiology of gastro-oesophageal reflux disease: a systematic review Gut 54 2005 710 717
34. J.P. Abonia, and M.E. Rothenberg Eosinophilic esophagitis: rapidly advancing insights Annu Rev Med 63 2012 421 434
35. B. Steinmann, P.M. Royce, and A. Superti-Furga The Ehlers-Danlos syndrome. Connective tissue and its heritable disorders 2002 John Wiley & Sons Hoboken (NJ) pp. 431-523
36. D.P. Judge, and H.C. Dietz Marfan's syndrome Lancet 366 2003 1965 1976
37. P. Beighton, P.A. De, B. Steinmann, P. Tsipouras, and R.J. Wenstrup Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK) Am J Med Genet 77 1998 31 37
38. B.L. Loeys, H.C. Dietz, A.C. Braverman, B.L. Callewaert, B.J. De, and R.B. Devereux The revised Ghent nosology for the Marfan syndrome J Med Genet 47 2010 476 485
39. J.R. Hall, R.E. Pyeritz, D.L. Dudgeon, and J.A. Haller Jr. Pneumothorax in the Marfan syndrome: prevalence and therapy Ann Thorac Surg 37 1984 500 504
40. K.K. Singh, K. Rommel, A. Mishra, M. Karck, A. Haverich, and J. Schmidtke TGFBR1 and TGFBR2 mutations in patients with features of Marfan syndrome and Loeys-Dietz syndrome Hum Mutat 27 2006 770 777
41. J.G. Clark, C. Kuhn III, and J. Uitto Lung collagen in type IV Ehlers-Danlos syndrome: ultrastructural and biochemical studies Am Rev Respir Dis 122 1980 971 978
42. L. Lucarini, L. Evangelisti, M. Attanasio, I. Lapini, F. Chiarini, and M.C. Porciani May TGFBR1 act also as low penetrance allele in Marfan syndrome? Int J Cardiol 131 2009 281 284
43. I. Loeffler, U. Hopfer, D. Koczan, and G. Wolf Type VIII collagen modulates TGF-beta1-induced proliferation of mesangial cells J Am Soc Nephrol 22 2011 649 663
44. J.P. Habashi, J.J. Doyle, T.M. Holm, H. Aziz, F. Schoenhoff, and D. Bedja Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism Science 332 2011 361 365
45. P. Matt, F. Schoenhoff, J. Habashi, T. Holm, E.C. Van, and D. Loch Circulating transforming growth factor-beta in Marfan syndrome Circulation 120 2009 526 532
46. T. Mizuguchi, G. Collod-Beroud, T. Akiyama, M. Abifadel, N. Harada, and T. Morisaki Heterozygous TGFBR2 mutations in Marfan syndrome Nat Genet 36 2004 855 860
47. G. Matyas, E. Arnold, T. Carrel, D. Baumgartner, C. Boileau, and W. Berger Identification and in silico analyses of novel TGFBR1 and TGFBR2 mutations in Marfan syndrome-related disorders Hum Mutat 27 2006 760 769
48. R. He, D.C. Guo, W. Sun, C.L. Papke, S. Duraisamy, and A.L. Estrera Characterization of the inflammatory cells in ascending thoracic aortic aneurysms in patients with Marfan syndrome, familial thoracic aortic aneurysms, and sporadic aneurysms J Thorac Cardiovasc Surg 136 2008 922 929
49. J.A. Jones, F.G. Spinale, and J.S. Ikonomidis Transforming growth factor-beta signaling in thoracic aortic aneurysm development: a paradox in pathogenesis J Vasc Res 46 2009 119 137
50. J.D. Gottsch, O.H. Sundin, S.H. Liu, A.S. Jun, K.W. Broman, and W.J. Stark Inheritance of a novel COL8A2 mutation defines a distinct early-onset subtype of Fuchs corneal dystrophy Invest Ophthalmol Vis Sci 46 2005 1934 1939
51. S.S. Aceves, R.O. Newbury, R. Dohil, J.F. Bastian, and D.H. Broide Esophageal remodeling in pediatric eosinophilic esophagitis J Allergy Clin Immunol 119 2007 206 212
52. A. Mishra, M. Wang, V.R. Pemmaraju, M.H. Collins, P.C. Fulkerson, and J.P. Abonia Esophageal remodeling develops as a consequence of tissue specific IL-5-induced eosinophilia Gastroenterology 134 2008 204 214
53. A. Straumann, S. Conus, P. Grzonka, H. Kita, G. Kephart, and C. Bussmann Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial Gut 59 2010 21 30
54. R.V. Lacro, H.C. Dietz, L.M. Wruck, T.J. Bradley, S.D. Colan, and R.B. Devereux Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome Am Heart J 154 2007 624 631
55. E. Moltzer, J. Essers, J.H. van Esch, J.W. Roos-Hesselink, and A.H. Danser The role of the renin-angiotensin system in thoracic aortic aneurysms: clinical implications Pharmacol Ther 131 2011 50 60
56. F.I. Gambarin, V. Favalli, A. Serio, M. Regazzi, M. Pasotti, and C. Klersy Rationale and design of a trial evaluating the effects of losartan vs. nebivolol vs. the association of both on the progression of aortic root dilation in Marfan syndrome with FBN1 gene mutations J Cardiovasc Med (Hagerstown) 10 2009 354 362
57. J.P. Habashi, D.P. Judge, T.M. Holm, R.D. Cohn, B.L. Loeys, and T.K. Cooper Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome Science 312 2006 117 121
58. T.M. Holm, J.P. Habashi, J.J. Doyle, D. Bedja, Y. Chen, and E.C. Van Noncanonical TGFbeta signaling contributes to aortic aneurysm progression in Marfan syndrome mice Science 332 2011 358 361
59. Y. Wang, H. Ait-Oufella, O. Herbin, P. Bonnin, B. Ramkhelawon, and S. Taleb TGF-beta activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice J Clin Invest 120 2010 422 432